Bioness launches StimRouter neuromod system in Canada

Rehabilitation device maker Bioness today touted the launch of its StimRouter neuromodulation system in Canada, and said that the system had been implanted in its first procedures in the region. The first implantations of the device were performed at Toronto’s Women’s College Hospital, the Valencia, Calif.-based company said. “Significant advances in the miniaturization and durability of neuromodulation devices have provided interventional pain physicians with the right tools, like the StimRouter PNS System, to treat chronic pain related to nerve injuries, trauma, stroke and other irreversible damages with a simple, minimally invasive procedure. Effective PNS may help reduce or even discontinue opioids that are commonly prescribed for these patients,” Dr. Michael Gofeld, who performed the first procedure to implant the StimRouter in Canada, said in a prepared statement. The StimRouter is a minimally-invasive, long-term perineuromodulation device designed to stimulate the peripheral nerve as a treatment for chronic pain originating in the peripheral nerve region, excluding pain in the craniofacial region. The StimRouter is designed to serve as an adjunct to other modes of therapy, Bioness said. “The approval of StimRouter in Canada is a tremendous step forward as we expand our non-drug solution to chronic pain of a peripheral nerve origin with a robust, validated, treatment for people seeking pain relief. It is our hope that the StimRouter wil...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Neuromodulation/Neurostimulation Bioness Source Type: news